Japan Tissue Engineering Cash Flow Statement

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2016 - 2020
Net Income	-234	147	-725	-494	-462	Upgrade
Depreciation & Amortization	158	134	131	124	128	Upgrade
Loss (Gain) From Sale of Assets	10	130	-	-	-	Upgrade
Other Operating Activities	-27	-3	-2	-1	-2	Upgrade
Change in Accounts Receivable	14	-32	-79	325	-140	Upgrade
Change in Inventory	46	9	-50	16	-38	Upgrade
Change in Accounts Payable	-4	-23	14	-114	90	Upgrade
Change in Other Net Operating Assets	-111	-88	89	-81	25	Upgrade
Operating Cash Flow	-148	274	-622	-225	-399	Upgrade
Capital Expenditures	-76	-196	-149	-103	-62	Upgrade
Sale (Purchase) of Intangibles	-17	-77	-26	-14	-12	Upgrade
Investment in Securities	-150	-100	1,300	-	200	Upgrade
Other Investing Activities	11	131	-1	1	-1	Upgrade
Investing Cash Flow	-232	-242	1,124	-116	125	Upgrade
Other Financing Activities	-	-	-	-	-1	Upgrade
Financing Cash Flow	-	-	-	-	-1	Upgrade
Miscellaneous Cash Flow Adjustments	-	-1	-1	-1	-	Upgrade
Net Cash Flow	-380	31	501	-342	-275	Upgrade
Free Cash Flow	-224	78	-771	-328	-461	Upgrade
Free Cash Flow Margin	-9.12%	3.10%	-37.94%	-15.60%	-20.42%	Upgrade
Free Cash Flow Per Share	-5.52	1.92	-18.98	-8.08	-11.35	Upgrade
Cash Income Tax Paid	27	3	3	3	3	Upgrade
Levered Free Cash Flow	-185.75	-82.38	-549	-70.25	-303.88	Upgrade
Unlevered Free Cash Flow	-185.75	-82.38	-549	-70.25	-303.88	Upgrade
Change in Net Working Capital	102	34	50	-234	66	Upgrade

Updated Jan 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.